RYUHX
Price
$19.57
Change
+$0.11 (+0.57%)
Updated
Jan 31 closing price
Net Assets
32.94M
RYURX
Price
$21.73
Change
+$0.12 (+0.56%)
Updated
Jan 31 closing price
Net Assets
32.94M
Ad is loading...

RYUHX vs RYURX

Header iconRYUHX vs RYURX Comparison
Open Charts RYUHX vs RYURXBanner chart's image
Rydex Inverse S&P 500® Strategy H
Price$19.57
Change+$0.11 (+0.57%)
VolumeN/A
Net Assets32.94M
Rydex Inverse S&P 500® Strategy I
Price$21.73
Change+$0.12 (+0.56%)
VolumeN/A
Net Assets32.94M
RYUHX vs RYURX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYUHX vs. RYURX commentary
Feb 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYUHX is a Hold and RYURX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYUHX (32.9M) and RYURX (32.9M) have equal amount of cash in the bank . RYUHX pays higher dividends than RYURX: RYUHX (3.32) vs RYURX (3.02). RYUHX was incepted earlier than RYURX: RYUHX (10 years) vs RYURX (31 years). RYUHX (2500) and RYURX (2500) have matching initial minimum investment requirements. RYURX (-14.27) and RYUHX (-14.41) have marching annual gain over last year. RYURX (-51.52) and RYUHX (-52.03) have equivalent 5 years return.
RYUHXRYURXRYUHX / RYURX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years31 years-
Gain YTD-2.200-2.206100%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/A1000-
Net Assets32.9M32.9M100%
Annual Yield % from dividends3.323.02110%
Returns for 1 year-14.41-14.27101%
Returns for 3 years-19.17-18.69103%
Returns for 5 years-52.03-51.52101%
Returns for 10 years-73.81-73.19101%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUGDF25.151.34
+5.63%
Lundin Gold Inc.
CIHKY28.130.44
+1.59%
China Merchants Bank Co., Ltd.
BZLFY21.480.31
+1.46%
Bunzl plc
MRAAY8.06-0.04
-0.49%
Murata Manufacturing Inc.
PVCT0.11N/A
-3.17%
Provectus Biopharmaceuticals, Inc.